Successful outcome of hepatic polycystic echinococcosis managed with surgery and chemotherapy

Siqueira, Nilton Ghiotti de; Almeida, Fernanda Barbosa de; Chalub, Sidney Raimundo Silva; Machado-Silva, José Roberto; Rodrigues-Silva, Rosângela

doi:10.1016/j.trstmh.2006.08.002

Cited by 13 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…By Mar. 2007, in 12 Latin American countries, 172 human cases of neotropical echinococcosis had been recorded (D'Alessandro and Rausch 2008), and at least eight further cases were reported thereafter (Siqueira et al, 2007(Siqueira et al, , 2010Knapp et al, 2009b). Most of the cases were caused by E. vogeli (for details see reviews by D'Alessandro and Rausch, 2008).…”

Section: Human Cases and Pathologymentioning

confidence: 99%

Historical Aspects of Echinococcosis

Eckert

Thompson

2017

Advances in Parasitology

View full text Add to dashboard Cite

Section: Human Cases and Pathologymentioning

confidence: 99%

Historical Aspects of Echinococcosis

Eckert

Thompson

2017

Advances in Parasitology

View full text Add to dashboard Cite

“…The only five patients that seem to have been cured were treated surgically with the additional chemotherapy with albendazole. CT scan and US, performed after treatment was terminated, were negative (10,29,42,44,49,53).…”

Section: Consequences Of Medical Treatmentmentioning

confidence: 99%

New Aspects of Neotropical Polycystic ( Echinococcus vogeli ) and Unicystic ( Echinococcus oligarthrus ) Echinococcosis

2008

View full text Add to dashboard Cite

SUMMARY Of the four species of the genus Echinococcus (Cestoda) distinguished by biological and morphological characteristics, two species, E. vogeli and E. oligarthrus, occur widely in the Neotropics. Approximately 200 cases of polycystic echinococcosis (PE) have been recorded from 12 countries in South America. Following early proliferation of E. vogeli in the human host, typically in the liver, the metacestode usually spreads in the peritoneal and pleural cavities, and numerous organs may be invaded. The clinical characteristics of PE in 81 patients with sufficient information are reviewed. Type I disease consists of polycysts in the liver and abdominal cavity (37% of the patients had this characteristic); type II is similar to type I but also includes hepatic insufficiency (26%); type III consists of cysts in liver and chest (14%); type IV consists of cysts only in the mesenteries (16%); and type V consists of cysts calcified in liver and lung (4%). The percentage of patients with polycysts in the liver was 81%, and the percentage of patients with polycysts in the chest was 14%. PE is most ready diagnosed by geographic origin of the patient and by means of ultrasound or computerized tomography scanning showing cysts and calcifications. The highest mortality was for patients with type II disease, due to hepatic failure and its complications. There were five patients who died due to surgical accidents, whereas 35 cases had uncomplicated surgery. Twenty-three patients died of PE, making the total mortality 29% (23 of 78 cases). None of the 13 patients treated only with albendazole, the most efficacious treatment, was completely cured. PE represents a severe medical problem in South America. A reevaluation of the characteristics of the metacestode of E. oligarthrus indicated that it is unicystic. Only three human cases are known (two with infection in the orbit and one with infection in the heart). The metacestode of E. oligarthrus, in contrast with that of E. vogeli, consists of a spherical, fluid-filled vesicle that enlarges concentrically and is not known to undergo exogenous proliferation.

show abstract

“…A combination of surgery with albendazole therapy is most likely to be successful. The principles of management for cystic and alveolar echinococcoses also apply to polycystic echinococcosis [47,48].…”

Section: Echinococcus Vogeli (Polycystic Echinococcosis)mentioning

confidence: 99%

Echinococcosis: A brief review

Moro

Schantz

2015

J Pediatr Infect Dis

View full text Add to dashboard Cite

Echinococcosis (hydatid disease) is the infection of humans by the larval stages of taeniid cestodes of the genus Echinococcus. Three species of public health importance, Echinococcus granulosus, E. multilocularis, and E. vogeli respectively, cause cystic, alveolar and polycystic echinococcosis respectively, and are the subject of this review. Several studies have shown that these diseases are an increasing public health concern and that both can be regarded as emerging or re-emerging diseases. In this review, we discuss aspects of their biology, life cycle, etiology, distribution, and transmission of the Echinococcus organisms, and the epidemiology, clinical features, treatment, and effect of improved diagnosis of the diseases they cause. New sensitive and specific diagnostic methods and effective therapeutic approaches against echinococcosis have been developed in the last 10 years. Despite some progress in the control of echinococcosis, this zoonosis continues to be a major public health problem in several countries and in several others; it constitutes an emerging and re-emerging disease.

show abstract

Successful outcome of hepatic polycystic echinococcosis managed with surgery and chemotherapy

Cited by 13 publications

References 5 publications

Historical Aspects of Echinococcosis

Historical Aspects of Echinococcosis

New Aspects of Neotropical Polycystic ( Echinococcus vogeli ) and Unicystic ( Echinococcus oligarthrus ) Echinococcosis

Echinococcosis: A brief review

Contact Info

Product

Resources

About